JHCB 📈 John Hancock - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US47804J8181 • Corporate Bond
JHCB: Corporate Bonds, Investment-Grade Bank Loans, Cash Equivalents
Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in corporate bonds. It may invest up to 20% of its net assets in investment-grade bank loans (including loan participations) and cash and cash equivalents. The fund may invest up to 10% of its total assets in securities denominated in foreign currencies.
Additional Sources for JHCB ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JHCB ETF Overview
| Market Cap in USD | 55m |
| Category | Corporate Bond |
| TER | 0.29% |
| IPO / Inception | 2021-03-30 |
JHCB ETF Ratings
| Growth 5y | 1.46% |
| Fundamental | - |
| Dividend | 66.9% |
| Rel. Strength Industry | 143 |
| Analysts | - |
| Fair Price Momentum | 20.38 USD |
| Fair Price DCF | - |
JHCB Dividends
| Dividend Yield 12m | 4.23% |
| Yield on Cost 5y | 4.13% |
| Annual Growth 5y | 15.03% |
| Payout Consistency | 100.0% |
JHCB Growth Ratios
| Growth Correlation 3m | -43.5% |
| Growth Correlation 12m | 83.3% |
| Growth Correlation 5y | -27.5% |
| CAGR 5y | -0.66% |
| CAGR/Mean DD 5y | -0.06 |
| Sharpe Ratio 12m | -0.27 |
| Alpha | -6.98 |
| Beta | 0.23 |
| Volatility | 6.65% |
| Current Volume | 1.9k |
| Average Volume 20d | 7.4k |
What is the price of JHCB stocks?
As of December 27, 2024, the stock is trading at USD 21.13 with a total of 1,878 shares traded.
Over the past week, the price has changed by +0.51%, over one month by -0.84%, over three months by -2.61% and over the past year by +3.21%.
As of December 27, 2024, the stock is trading at USD 21.13 with a total of 1,878 shares traded.
Over the past week, the price has changed by +0.51%, over one month by -0.84%, over three months by -2.61% and over the past year by +3.21%.
Is John Hancock a good stock to buy?
Neither. Based on ValueRay Analyses, John Hancock is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.46 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JHCB as of December 2024 is 20.38. This means that JHCB is currently overvalued and has a potential downside of -3.55%.
Neither. Based on ValueRay Analyses, John Hancock is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.46 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JHCB as of December 2024 is 20.38. This means that JHCB is currently overvalued and has a potential downside of -3.55%.
Is JHCB a buy, sell or hold?
John Hancock has no consensus analysts rating.
John Hancock has no consensus analysts rating.
What are the forecast for JHCB stock price target?
According to ValueRays Forecast Model, JHCB John Hancock will be worth about 22.1 in December 2025. The stock is currently trading at 21.13. This means that the stock has a potential upside of +4.64%.
According to ValueRays Forecast Model, JHCB John Hancock will be worth about 22.1 in December 2025. The stock is currently trading at 21.13. This means that the stock has a potential upside of +4.64%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.1 | 4.6% |